Status:

UNKNOWN

Selective Reporting for Antibiotic Susceptibility Testing and GPs' Prescribing of Broad-spectrum Antibiotics in Women With E. Coli UTIs

Lead Sponsor:

Nantes University Hospital

Conditions:

Urinary Tract Infections

Eligibility:

FEMALE

18+ years

Phase:

NA

Brief Summary

The control of antibiotic resistance requires a reduction in inappropriate prescriptions of broad-spectrum antibiotics (amoxillin-clavulanate (AMC), fluoroquinolones (FQ), third-generation cephalospor...

Eligibility Criteria

Inclusion

  • Patients :
  • women ≥18 years of age,
  • affiliated with the CPAM of Loire Atlantique (44) or Maine et Loire (49),
  • with a urine culture: i) analyzed by LabOuest, ii) positive for E. coli, and iii) associated with a prescription for antibiotics by a general practitioner in the period 7 days before and 14 days after the antibiotic susceptibility testing.
  • General practitioners :
  • practicing in primary care Loire Atlantique (44) and/or Maine et Loire (49),
  • having been consulted by at least 100 different patients in the 12 months prior to baseline,
  • having received at least one urine culture result for a woman ≥18 years of age analyzed by LabOuest over the 12 months prior to baseline.

Exclusion

  • Patients :
  • hospitalized in the period 7 days before and 14 days after antibiotic susceptibility testing (data on antibiotics dispensed in healthcare institutions are not accessible via DCIR data),
  • with reimbursements for antibiotics prescribed by physicians in different practices over the period 7 days before and 14 days after antibiotic susceptibility testing.
  • General practitioners :
  • with a special practice (acupuncture, allergology, angiology).
  • not receiving any urine culture results analyzed by a laboratory of the LabOuest network in the year following the intervention

Key Trial Info

Start Date :

November 21 2023

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

November 21 2024

Estimated Enrollment :

3000 Patients enrolled

Trial Details

Trial ID

NCT06067386

Start Date

November 21 2023

End Date

November 21 2024

Last Update

April 22 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University Hospital

Nantes, France, 44000